Wordt geladen...
FDA efficiency for approval process of COVID-19 therapeutics
Coronavirus disease 19 (COVID-19) is an infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The pandemic spread of SARS-CoV-2 has resulted in significant health, economic, and social ramifications. There are no U.S. Food and Drug Administration (FDA)-approved...
Bewaard in:
| Gepubliceerd in: | Infect Agent Cancer |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7705854/ https://ncbi.nlm.nih.gov/pubmed/33292374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-020-00338-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|